Tag: Pricing Technology

Trump’s Drug Blueprint Could Alter PBM Contracting | SHRM

Trump’s Drug Blueprint Could Alter PBM Contracting | SHRM

With much fanfare, President Donald Trump’s administration recently released a 44-page blueprint for executive action on drug pricing titled American Patients First. The blueprint proposes steps to end drug manufacturers’ “gaming” of the regulatory process and to create incentives for pharmaceutical companies to lower list prices. The proposals regarding pharmacy benefit manager (PBM) firms, in […]

Pass pharma discounts onto patients, not ‘highly-paid middlemen’, says expert | thepharmaletter

Pass pharma discounts onto patients, not ‘highly-paid middlemen’, says expert | thepharmaletter

Dr Matthews said: “Price transparency in health care, and especially pharmaceuticals, has become a major policy debate. “But price transparency is a problem in the whole health care system. Try calling a hospital to get a quote for the cost of an appendectomy. At least with prescription drugs, a patient can obtain and compare prices […]

Study Shows Customer Preference for Direct Delivery from Restaurants | Food On Demand

Study Shows Customer Preference for Direct Delivery from Restaurants | Food On Demand

Customers report they would order from their favorite restaurants one extra time per month if delivery was offered, and more than 70 percent of QSR and fast-casual customers said they would choose a restaurant more often if delivery were offered. The importance of delivery doesn’t apply only to millennials. Of customers 35-44, around 78 percent […]

Would requiring drug advertisements to list price tags really help lower prices? | THE BUSINESS TIMES

Would requiring drug advertisements to list price tags really help lower prices? | THE BUSINESS TIMES

IF US President Donald Trump has his way, television viewers who see commercials for the drug Keytruda will learn not only that it can help lung cancer patients, but also that it carries a price tag of US$13,500 a month, or US$162,000 a year. Viewers who see advertisements for Neulasta, a drug that reduces the […]

Requiring Prices in Drug Ads: Would It Do Any Good? Is It Even Legal? | The New York Times

Requiring Prices in Drug Ads: Would It Do Any Good? Is It Even Legal? | The New York Times

WASHINGTON — If President Trump has his way, television viewers who see commercials for the drug Keytruda will learn not only that it can help lung cancer patients, but also that it carries a price tag of $13,500 a month, or $162,000 a year. Viewers who see advertisements for Neulasta, a drug that reduces the […]

Prescription drug prices: 3 ways Trump can drive them lower | WND

Prescription drug prices: 3 ways Trump can drive them lower | WND

“Distributors, called pharmacy benefit managers, have set up their businesses to help provide not only distribution supply chains so these institutions have their medicines but also to try to negotiate big discounts for them,” Turner told WND and Radio America. “There are questions about how much of that money – the discounts – is actually […]

Congress and regulators slow to respond to drug pricing and shortage problem | TheHill

Congress and regulators slow to respond to drug pricing and shortage problem | TheHill

Conversely, unethical pharmaceutical companies continue their practice of price gouging, a naked effort to maximize short-term profits at the expense of patients who desperately need their medications. More than 300 generic drugs had price increases of 100 percent or more between 2010 and 2015, according to a U.S. Government Accountability Office report on Medicare drug […]

Behavioral Economics Powered by Machine Learning and AI Techniques | Pricing Matters

Behavioral Economics Powered by Machine Learning and AI Techniques | Pricing Matters

There is a growing focus among pricing practitioners to use price science to drive pricing decisions. It’s a fabulous trend with many recent innovations in the use of advanced techniques such as machine learning and AI. It is important however to consider behavioral economics because our economic decision making is often shockingly irrational. Naturally, we […]

Massachusetts Rejects Smart Meter Rollouts, as Competitive Energy Undermines the Business Case | Greentech Media

Massachusetts Rejects Smart Meter Rollouts, as Competitive Energy Undermines the Business Case | Greentech Media

The problem is that each utility customer that switches to a non-utility energy provider is no longer part of each utility’s list of prospective time-varying rate (TVR) adopters, even though the utility paid for the smart meter that made them available. And while third-party retailers and municipal aggregators could offer TVRs of their own, “there […]

Amgen’s Just-Approved Migraine Drug Will Cost $6,900 a Year | Bloomberg

Amgen’s Just-Approved Migraine Drug Will Cost $6,900 a Year | Bloomberg

Renewed political pressure over drug costs has added to the challenge of finding the right price for innovative medications. While drugmakers want to maximize returns on the substantial investment required to develop new therapies, some payers have begun to push back. A pricing misstep helped slow sales of Amgen’s cholesterol fighter Repatha, which failed to […]